Vontobel Holding
BCYC

Vontobel Holding’s Bicycle Therapeutics BCYC Stock Holding History

Vontobel Holding’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.8K Hold
20,000
– – ﹤0.01% 1421
2026
Q1 		$92.8K Buy
20,000
+10,000
+100% +$57.1K ﹤0.01% 1153
2025
Q4 		$70.8K Buy
+10,000
New +$73.7K ﹤0.01% 1385

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vontobel Holding's BCYC Position: Q2 2026 in Review

Vontobel Holding held its Bicycle Therapeutics (BCYC) position steady in Q2 2026 at 20,000 shares worth $84.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1421.

Vontobel Holding first reported a position in BCYC in Q4 2025 and has held it in 3 quarters since. The position peaked at $92.8K in Q1 2026. 103 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Vontobel Holding held 20,000 shares of Bicycle Therapeutics worth $84.8K as of Q2 2026.
  • Vontobel Holding left its Bicycle Therapeutics share count unchanged in Q2 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1421 holding.
  • Vontobel Holding first reported a position in Bicycle Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Vontobel Holding's Bicycle Therapeutics position peaked at $92.8K in Q1 2026.
  • 103 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.